Disease modifying therapies in multiple sclerosis: Could a baseline thyroid check-up drive the therapeutic choice between interferon-β and glatiramer acetate? Rotondi M, Bergamaschi R, Chiovato L Mult Scler. 2014 May 8. PMID: 24812044. Abstract CommentRecommendBookmarkWatch